Literature DB >> 21078804

The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.

Massimo Castellani1, Alessandro Colombo, Rosaria Giordano, Enrico Pusineri, Cristina Canzi, Virgilio Longari, Emanuela Piccaluga, Simone Palatresi, Luca Dellavedova, Davide Soligo, Paolo Rebulla, Paolo Gerundini.   

Abstract

UNLABELLED: Over the last decade, the effects of stem cell therapy on cardiac repair after acute myocardial infarction (AMI) have been investigated with different imaging techniques. We evaluated a new imaging approach using (13)N-ammonia and (18)F-FDG PET for a combined analysis of cardiac perfusion, metabolism, and function in patients treated with intracoronary injection of endothelial progenitors or with conventional therapy for AMI.
METHODS: A total of 15 patients were randomly assigned to 3 groups based on different treatments (group A: bone marrow-derived stem cells; group B: peripheral blood-derived stem cells; group C: standard therapy alone). The number of scarred and viable segments, along with the infarct size and the extent of the viable area, were determined on a 9-segment (13)N-ammonia/(18)F-FDG PET polar map. Myocardial blood flow (MBF) was calculated for each segment on the ammonia polar map, whereas a global evaluation of left ventricular function was obtained by estimating left ventricular ejection fraction (LVEF) and end-diastolic volume, both derived from electrocardiography-gated (18)F-FDG images. Both intragroup and intergroup comparative analyses of the mean values of each parameter were performed at baseline and 3, 6, and 12 mo after AMI. During follow-up, major cardiac events were also registered.
RESULTS: A significant decrease (P < 0.05) in the number of scarred segments and infarct size was observed in group A, along with an increase in MBF (P < 0.05) and a mild improvement in cardiac function. Lack of infarct size shrinkage in group B was associated with a marked impairment of MBF (P = 0.01) and cardiac dysfunction. Ambiguous changes in infarct size, MBF, and LVEF were found in group C. No differences in number of viable segments or in extent of viable area were found among the groups. At clinical follow-up, no major cardiac events occurred in group A patients, whereas 2 patients of group B experienced in-stent occlusion and one patient of group C received a transplant for heart failure.
CONCLUSION: Our data suggest that a single nuclear imaging technique accurately analyzes changes in myocardial perfusion and metabolism occurring after stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078804     DOI: 10.2967/jnumed.110.078469

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

2.  Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques.

Authors:  Yingli Fu; Nicole Azene; Yi Xu; Dara L Kraitchman
Journal:  Imaging Med       Date:  2011-08-01

3.  Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Authors:  Christoph Rischpler; Ralf J Dirschinger; Stephan G Nekolla; Hans Kossmann; Stefania Nicolosi; Franziska Hanus; Sandra van Marwick; Karl P Kunze; Alexander Meinicke; Katharina Götze; Adnan Kastrati; Nicolas Langwieser; Tareq Ibrahim; Matthias Nahrendorf; Markus Schwaiger; Karl-Ludwig Laugwitz
Journal:  Circ Cardiovasc Imaging       Date:  2016-04       Impact factor: 7.792

4.  Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction.

Authors:  Linjun Hao; Jin Hao; Wei Fang; Chunlei Han; Kaixiu Zhang; Xuemei Wang
Journal:  Biomed Rep       Date:  2015-05-27

Review 5.  SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.

Authors:  George A Beller; Ruth C Heede
Journal:  J Cardiovasc Transl Res       Date:  2011-07-06       Impact factor: 4.132

Review 6.  Vascular stem cells-potential for clinical application.

Authors:  Sadie C Slater; Michele Carrabba; Paolo Madeddu
Journal:  Br Med Bull       Date:  2016-06       Impact factor: 4.291

Review 7.  Imaging: guiding the clinical translation of cardiac stem cell therapy.

Authors:  Patricia K Nguyen; Feng Lan; Yongming Wang; Joseph C Wu
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

Review 8.  Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT?

Authors:  Quynh A Truong; Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

Review 9.  Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.

Authors:  Rosalinda Madonna; Linda W Van Laake; Sean M Davidson; Felix B Engel; Derek J Hausenloy; Sandrine Lecour; Jonathan Leor; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus; Ulf Landmesser; Christine L Mummery; Stefan Janssens; James Willerson; Thomas Eschenhagen; Péter Ferdinandy; Joost P G Sluijter
Journal:  Eur Heart J       Date:  2016-04-07       Impact factor: 29.983

10.  Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go?

Authors:  Linda A Jelicks; Wade Koba; Herbert B Tanowitz; Rosalia Mendez-Otero; Antonio C Campos de Carvalho; David C Spray
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.